Trial to Test Effectiveness of Depression Intervention for Mistreated Older Adults
EM/PROTECT-Hybrid: Improving Depression in Elder Mistreatment Victims
2 other identifiers
interventional
40
1 country
1
Brief Summary
The investigators developed EM/PROTECT, a behavioral intervention for depressed EM (elderly mistreatment) victims, to work in synergy with EM mistreatment resolution services that provide safety planning, support services, and links to legal services. PROTECT is built on a model which postulates that chronic stress promotes dysfunction of the cognitive control (CCN) and reward networks, impairing the victims' ability to flexibly respond to the environment and limits their reward activities. PROTECT therapists work with victims to develop action plans to reduce stress, and to increase rewarding experiences. EM/PROTECT has been designed in an iterative process with community EM providers of the New York City (NYC) Department for the Aging (DFTA) to use agencies' routine PHQ-9 depression screening and referral for service. In the current study, the investigators will compare the effectiveness of EM/PROTECT with EM enriched with staff training in linking EM victims to community mental health services (EM/MH). The investigators intend to enroll 50 subjects that will participate in the study for approximately 12 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 6, 2020
CompletedStudy Start
First participant enrolled
July 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 11, 2022
CompletedResults Posted
Study results publicly available
August 28, 2023
CompletedAugust 28, 2023
August 1, 2023
2.1 years
February 4, 2020
June 9, 2023
August 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Clinically Significant Depressive Symptoms as Measured by the MADRS
In all conditions, the change in clinically significant depressive symptoms as measured on the Montgomery Asberg Depression Rating Scale (MADRS). Scores are categorized as following: 0 to 6 - Normal /symptom absent. 7 to 19 - Mild depression. 20 to 34 - Moderate depression. \>34 - Severe depression. The scores presented for each time point are absolute values.
6 weeks, 9 weeks, 12 weeks
Change in Assessment of Quality of Life, as Measured by the WHO-QOL
In all conditions, changes in assessment of quality of life measured by the World Health Organization Quality of Life (WHO-QOL) scale. World Health Organization-Quality Of Life scale. The overall scores range between 26-130. In all domains, higher scores indicate better health. Domain 1 measures physical health (scores range from 7-35). Domain 2 measures psychological health (scores range from 6-30). Domain 3 measures social health (scores range from 3-15). Domain 4 measures environmental health (scores range from 8-40). The scores presented for each time point are absolute values.
6 weeks, 9 weeks, 12 weeks
Change in Assessment of Stress, as Measured by the PSS
In all conditions, changes in assessment of stress measured by the Perceived Stress Scale (PSS) scale. Scores range from 0-40. Scores ranging from 0-13 are considered low stress, scores ranging from 14-26 are considered moderate stress, and scores ranging from 27-40 are considered high perceived stress.
Baseline, 6 weeks
Secondary Outcomes (1)
Change in Assessment of Exposure to Meaningful Activities, as Measured by the BADS
Baseline, 6 weeks
Study Arms (1)
Video PROTECT
EXPERIMENTALParticipants will receive PROTECT therapy once a week for 9 weeks.
Interventions
PROTECT is a therapeutic intervention focused on treating victims of elder abuse who are experiencing depression. PROTECT therapy will be delivered through video. Participants will be provided with a mobile device (iPhone), and a wearable device (smart watch) that will track sleep, mood, steps, and heart rate.
Eligibility Criteria
You may qualify if:
- years of age or older
- Capacity to consent (per Elder Mistreatment staff)
- Significant depression (per Elder Mistreatment staff) as indicated by a score of 10 or above on the Patient Health Questionnaire-9 (PHQ-9), a widely used screening tool routinely administered in Elder Mistreatment (EM) agency settings (the PHQ-9 has a sensitivity of 88% and a specificity of 88% for major depression)
- Need for EM services
You may not qualify if:
- Active suicidal ideation (Montgomery Asberg Depression Rating Scale item 10\>4)
- Inability to speak English or Spanish
- Axis 1 Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) diagnoses other than unipolar depression or generalized anxiety disorder (by Structured Clinical Interview for DSM-5)
- Severe or life-threatening medical illness
- EM emergency and or referral out of EM agency (per EM staff)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medicine
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Jo Anne Sirey
- Organization
- Weill Cornell Medical College
Study Officials
- PRINCIPAL INVESTIGATOR
Jo Anne Sirey, Ph.D.
Weill Medical College of Cornell University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2020
First Posted
February 6, 2020
Study Start
July 15, 2020
Primary Completion
August 11, 2022
Study Completion
August 11, 2022
Last Updated
August 28, 2023
Results First Posted
August 28, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be available as per the National Institute of Mental Health (NIMH) data sharing policy.
- Access Criteria
- Access criteria is determined by NIMH and can be requested by applying online.
De-identified data from this study is submitted to the National Database for Clinical Trials related to Mental Illness (NDCT). The NDCT is run by the National Institute of Health (NIH) and allows researchers studying mental health to collect and share information with each other. Researchers must apply to NIH in order to be allowed access to the data for 1 year's time; after which they must re-apply.